TABLE 4.

Post-operative outcomes.

	Total (n = 78)			Grade 2 nuclei (n = 27)			Grade 3 nuclei (n = 51)
	Active (n = 40)	Gravity (n = 38)	P-value	Active (n = 15)	Gravity (n = 12)	P-value	Active (n = 25)	Gravity (n = 26)	P-value
P1D BCVA, LogMAR	0.10 ± 0.11	0.27 ± 0.18	<0.0001	0.10 ± 0.10	0.25 ± 0.16	<0.0001	0.10 ± 0.12	0.28 ± 0.19	<0.0001
P1W BCVA, LogMAR	0.08 ± 0.09	0.11 ± 0.13	0.127	0.08 ± 0.09	0.11 ± 0.14	0.135	0.08 ± 0.09	0.11 ± 0.13	0.155
P1M BCVA, LogMAR	0.08 ± 0.10	0.10 ± 0.13	0.428	0.08 ± 0.08	0.10 ± 0.11	0.399	0.08 ± 0.11	0.10 ± 0.16	0.532
P1D corneal edema
None	31(77.5%)	11(28.9%)	<0.001	13(86.7%)	3(25.0%)	0.004	18(72.0%)	7(26.9%)	0.018
Mild	7(17.5%)	19(50.0%)		2(13.3%)	6(50.0%)		5(20.0%)	14(53.8%)
Moderate	2(5.0%)	7(18.4%)		0(0.0%)	3(25.0%)		2(8.0%)	4(15.4%)
Severe	0(0.0%)	1(2.6%)		0(0.0%)	0(0.0%)		0(0.0%)	1(3.8%)
P1W corneal edema
None	39(97.5%)	37(97.4%)	0.971	14(93.3%)	12(100.0%)	0.362	25(100.0%)	25(96.2%)	0.322
Mild	1(2.5%)	1(2.6%)		1(6.7%)	0(0.0%)		0(0.0%)	1(3.8%)
Moderate	0(0.0%)	0(0.0%)		0(0.0%)	0(0.0%)		0(0.0%)	0(0.0%)
Severe	0(0.0%)	0(0.0%)		0(0.0%)	0(0.0%)		0(0.0%)	0(0.0%)
P1D CCT (μm)	579.2 ± 122.1	618.6 ± 157.9	0.015	569.8 ± 98.7	608.6 ± 113.3	0.039	584.8 ± 132.5	623.2 ± 192.2	0.011
Change of P1D CCT (%)	7.0 ± 3.1	15.3 ± 6.2	0.031	5.3 ± 2.2	13.4 ± 5.9	0.023	8.1 ± 3.9	16.2 ± 7.0	0.003
P1W CCT (μm)	555.9 ± 109.2	578.3 ± 131.1	0.159	549.1 ± 94.1	558.1 ± 99.8	0.447	560.0 ± 119.9	587.6 ± 146.8	0.274
Change of P1W CCT (%)	2.7 ± 2.5	7.8 ± 6.8	0.112	1.5 ± 1.2	4.0 ± 3.6	0.129	3.5 ± 2.2	9.4 ± 7.7	0.258
P1M ECD	1056.3 ± 294.2	863.7 ± 205.2	0.022	1089.8 ± 378.9	853.3 ± 291.5	0.032	1036.2 ± 209.2	868.5 ± 223.3	0.007
Loss rate of ECD (%)	13.0 ± 4.2	31.2 ± 9.8	0.018	12.0 ± 3.5	33.1 ± 8.9	0.009	13.6 ± 4.8	30.4 ± 10.3	0.003

CCT, corneal central thickness; ECD, endothelial cell density; P1D, one day after surgery; P1W, one week after surgery; P1M, one month after surgery.